Melanoma: all 3,073 studies
Page 23 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.
- Validation of MMS Test for Cancer MonitoringTerminatedNCT02113683
- Treatment of Advanced Melanoma With MK-3475 and PeginterferonCompletedNCT02112032Phase 1
- A Phase 1b/2a Study Evaluating AMG 232 in Metastatic MelanomaCompletedNCT02110355Phase 1
- Identification of Marker of Primary or Acquired Resistance to Anti Tumorous TreatmentStatus unknownNCT02105168Not applicable
- Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases MelanomaCompletedNCT02094391Phase 2
- Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)CompletedNCT02088762
- Program for Pembrolizumab (MK-3475) in Participants With Metastatic Melanoma Who Have Failed Standard of Care Therapy Including Ipilimumab (MK-3475-030)No longer availableNCT02083484
- Vaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant MelanomaCompletedNCT02077114Phase 1
- A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic MelanomaStatus unknownNCT02076646Phase 1/2
- Intratumoral Administration of L19IL2/L19TNFCompletedNCT02076633Phase 2
- Cognitive Effects of Interferon in Patients With MelanomaCompletedNCT02074605
- PLX3397 KIT in Acral aNd mucOsal MelanomaCompletedNCT02071940Phase 2
- Ensuring Communication in Hospice by Oncology Study (ECHO)CompletedNCT02069769Not applicable
- A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.Active, not recruitingNCT02068196Phase 4
- A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic MelanomaWithdrawnNCT02068079Phase 1
- Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain MetastasesWithdrawnNCT02065466Phase 1/2
- Biomarker Correlates of Hypoxia in Metastatic MelanomaWithdrawnNCT02061007Phase 2
- CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain MetastasesCompletedNCT02058953
- Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical ImagingCompletedNCT02056522
- Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb StudyTerminatedNCT02052193Phase 2
- Ipilimumab 12-month Intensive Pharmacovigilance ProtocolCompletedNCT02050594
- Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot StudyCompletedNCT02038348Phase 2
- Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node MetastasesStatus unknownNCT02036086Phase 2
- IVAC MUTANOME Phase I Clinical TrialCompletedNCT02035956Phase 1
- RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVERCompletedNCT02029729Phase 1
- Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib AloneCompletedNCT02027961Phase 1
- Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal MelanomaStatus unknownNCT02023710Phase 2
- Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
- A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic CancerCompletedNCT02015416Phase 1
- Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By SurgeryCompletedNCT02013492Early Phase 1
- Nevus Doctor Clinical Decision SupportCompletedNCT02012751Not applicable
- Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.TerminatedNCT02012231Phase 1
- A Pilot Study of Ipilumimab and Radiation in Poor Prognosis MelanomaCompletedNCT01996202Phase 1
- TIL Therapy in Metastatic Melanoma and IL2 Dose AssessmentTerminatedNCT01995344Phase 2
- In Vivo Confocal Microscopy Study of Pigmented Conjunctival LesionsTerminatedNCT01993654
- An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)CompletedNCT01990248
- Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant MelanomaActive, not recruitingNCT01989585Phase 1/2
- Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By SurgeryCompletedNCT01989559Phase 1
- Efficacy of Propranolol Treatment to Prevent Melanoma ProgressionSuspendedNCT01988831Phase 2
- A Two-arm, Single Center Phase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma PatientsTerminatedNCT01984255Phase 1
- Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on VemurafenibCompletedNCT01983124Phase 2
- Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II StudyCompletedNCT01973322Phase 2
- Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive MelanomaCompletedNCT01972347Phase 2
- Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety StudyStatus unknownNCT01960829Phase 2
- Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic MelanomaCompletedNCT01960634
- Vemurafenib Plus Cobimetinib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF MutationCompletedNCT01959633Phase 1/2
- Vascular Response to Brachytherapy Using Functional OCTCompletedNCT01955941
- Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV MelanomaActive, not recruitingNCT01955460Phase 1
- SRS (Stereotactic Radiosurgery) Plus IpilimumabTerminatedNCT01950195Phase 1
- Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV MelanomaTerminatedNCT01944709Phase 1/2
- Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in MelanomaCompletedNCT01943422Phase 1
- Minimal SN Tumor BurdenActive, not recruitingNCT01942603
- Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by SurgeryTerminatedNCT01940809Phase 1
- Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic MelanomaWithdrawnNCT01933061Phase 2
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Definity for Ultrasound of Intraocular TumorsWithdrawnNCT01930968
- BAP1 Testing in Instance Choroidal Nevi or Uveal MelanomaStatus unknownNCT01925599
- Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2TerminatedNCT01925118Phase 2
- New Biopsy Technique for Uveal MelanomaCompletedNCT01924923
- Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma TreatmentStatus unknownNCT01920516
- Tissue Procurement Substudy for Participants in Study CP-MGA271-01TerminatedNCT01918930Phase 1
- PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-DerivativeCompletedNCT01916135Phase 1
- STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the BrainCompletedNCT01904123Phase 1
- An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic MelanomaCompletedNCT01898585Phase 4
- A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant MelanomaCompletedNCT01897116Phase 1
- Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular MelanomaCompletedNCT01893099Phase 1
- A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV MelanomaTerminatedNCT01888081Phase 1/2
- Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2CompletedNCT01884961Phase 2
- Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With MelanomaCompletedNCT01883323Phase 2
- Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF InhibitorsStatus unknownNCT01878396
- Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib Plus CobimetinibTerminatedNCT01876641Phase 1
- Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic MelanomaTerminatedNCT01875653Phase 3
- Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic MelanomaCompletedNCT01864759Phase 1
- Safety Study of a Dendritic Cell-based Cancer Vaccine in MelanomaCompletedNCT01863108Phase 1
- Modified Melanoma Vaccine for High Risk or Low Residual Disease PatientsWithdrawnNCT01861938Phase 2/3
- Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of MelanomaCompletedNCT01859845Not applicable
- A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic MalignancyCompletedNCT01851824Phase 1
- Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaWithdrawnNCT01851408Phase 2
- A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic MalignancyCompletedNCT01849666Phase 1
- Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced MalignanciesCompletedNCT01846143Phase 1
- A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic MalignanciesCompletedNCT01844674Phase 1
- Radiation Use During Vemurafenib TreatmentWithdrawnNCT01843738Phase 1
- Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF MutationSuspendedNCT01841463Phase 1
- Pilot Study Evaluating the Efficacy and Safety of Metformin in MelanomaCompletedNCT01840007Phase 2
- Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By SurgeryTerminatedNCT01835184Phase 1
- Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic MelanomaWithdrawnNCT01833767Phase 2
- Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II MelanomaWithdrawnNCT01826864Phase 3
- Second Echelon Node Study With Methylene BlueCompletedNCT01823172Not applicable
- Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab TherapyCompletedNCT01789827Early Phase 1
- The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver MetastasesCompletedNCT01785316Phase 3
- Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic CellsTerminatedNCT01783431Phase 1
- A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated MelanomaStatus unknownNCT01782508Phase 2
- Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or BrachytherapyCompletedNCT01777802
- A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment CharacteristicsCompletedNCT01775514
- Clinical and Histopathologic Characteristics of BAP1 MutationsCompletedNCT01773655
- Set-back Suture Versus Traditional Vertical Mattress SutureCompletedNCT01773447Not applicable
- Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable MelanomaCompletedNCT01767454Phase 1
- A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic MelanomaWithdrawnNCT01765556Phase 1
- Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic MelanomaWithdrawnNCT01764009Phase 1/2
- Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility StudyCompletedNCT01760499Phase 1